BioSpace News Archive

Ligand Pharmaceuticals Incorporated reported financial results for the three and six months ended June 30, 2021 and provided an operating forecast and program updates.

CooperCompanies, announced it will release third quarter 2021 financial results on Thursday, September 2, 2021, at 4:15 PM ET.

Gilead Sciences, Inc. (Nasdaq: GILD) announced today its results of operations for the second quarter 2021.

Baxter International Inc. (NYSE:BAX), a leading global medical products company, announced its Baxter Healthcare Corporation subsidiary has completed the acquisition of certain assets related to PerClot Polysaccharide Hemostatic System from CryoLife, Inc (NYSE:CRY) for up to $60.8 million, including $25 million paid upfront.

Mycovia Pharmaceuticals, Inc. (Mycovia), today announced that data from its Phase 3, randomized, double-blind, placebo-controlled VIOLET studies to measure the efficacy and safety of oteseconazole (VT-1161) for the treatment of recurrent vulvovaginal candidiasis (RVVC) will be presented at the 2021 Virtual Annual Meeting of the Infectious Diseases Society for Obstetrics and Gynecology (IDSOG).

Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) will host a conference call at 8:00 a.m. ET Thursday, August 5, 2021 to report financial results for the quarter ended June 30, 2021 and discuss recent business highlights.

Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, today announced the appointment of Michael Rabinowitz to the newly created position of Chief Commercial Officer effective August 1, 2021.

Veru Inc., an oncology biopharmaceutical company with a focus on developing novel medicines for the management of prostate and breast cancer, announced that it will report financial results for its fiscal 2021 third quarter on Thursday, August 12, 2021, before the market opens.

Quotient Limited, a commercial-stage diagnostics company, announced that financial results for its fiscal first quarter ended June 30, 2021 will be released before market open on Thursday, August 5, 2021.

Cryoport, Inc., a global leader in temperature-controlled supply chain solutions for the life sciences industry, announced that the Company will report financial results for the second quarter ended June 30, 2021 on Thursday, August 5, 2021 after U.S. markets close.